Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls
Bernard Keavney(Manchester Academic Health Science Centre), Rory Collins(University of Oxford), Sarah J. Clark(University of Oxford), Linda Youngman(University of Oxford), Sarah Parish(University of Oxford), A. W. Palmer(University of Oxford), Mark Lathrop(Centre for Human Genetics), Marc Délepine(Centre National de Recherche en Génomique Humaine), Colin A. McKenzie(Centre for Human Genetics), Richard Peto(University of Oxford)
Cited by 342
Related Papers
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k
Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies
|International Journal of Epidemiology|2019|1.4k
Quality of primary health care in China: challenges and recommendations
|The Lancet|2020|919
The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK
|The Lancet|2012|835
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults
|Journal of the American College of Cardiology|2018|832